ResearcherShanghai UniversityNo recent work listed

Fei Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7888-625X; OpenAlex author ID A5023874796. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper

Papers 1

Prognostic Evaluation Based on Dual-Time 18F-FDG PET/CT Radiomics Features in Patients with Locally Advanced Pancreatic Cancer Treated by Stereotactic Body Rad… Co-author DOI 10.1155/2022/6528865 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shengnan Ren · 1 shared paper, 2022 · strength 0.16
- Paper Prognostic Evaluation Based on Dual-Time 18F-FDG PET/CT Radiomics Features in Patients with Locally Advanced Pancreatic… DOI 10.1155/2022/6528865 ↗
Changjing Zuo · 1 shared paper, 2022 · strength 0.16
- Paper Prognostic Evaluation Based on Dual-Time 18F-FDG PET/CT Radiomics Features in Patients with Locally Advanced Pancreatic… DOI 10.1155/2022/6528865 ↗
Chao Cheng · 1 shared paper, 2022 · strength 0.16
- Paper Prognostic Evaluation Based on Dual-Time 18F-FDG PET/CT Radiomics Features in Patients with Locally Advanced Pancreatic… DOI 10.1155/2022/6528865 ↗
Xiaodong Yang · 1 shared paper, 2022 · strength 0.16
- Paper Prognostic Evaluation Based on Dual-Time 18F-FDG PET/CT Radiomics Features in Patients with Locally Advanced Pancreatic… DOI 10.1155/2022/6528865 ↗
Zhaobang Liu · 1 shared paper, 2022 · strength 0.16
- Paper Prognostic Evaluation Based on Dual-Time 18F-FDG PET/CT Radiomics Features in Patients with Locally Advanced Pancreatic… DOI 10.1155/2022/6528865 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.